Patents by Inventor Erick Young

Erick Young has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBSTITUTED 3-AMINO-THIENO[2,3-b]PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES
    Publication number: 20070293533
    Abstract: Disclosed are compounds of formula (I): wherein R1 and R4 are defined herein, which are useful as inhibitors of the kinase activity of the I?B kinase (IKK) complex. The compounds are therefore useful in the treatment of IKK mediated diseases including autoimmune diseases inflammatory diseases, cardiovascular disease and cancer. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.
    Type: Application
    Filed: May 31, 2007
    Publication date: December 20, 2007
    Inventors: John GINN, Ronald Sorcek, Michael Turner, Erick Young
  • Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
    Publication number: 20060270671
    Abstract: Disclosed are methods of treating cancer by administration of compounds according to formula (I): wherein the variables R1, R2, R3 and Z are described herein.
    Type: Application
    Filed: August 7, 2006
    Publication date: November 30, 2006
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Zhidong Chen, Pier Cirillo, Darren DiSalvo, Weimin Liu, Daniel Marshall, Lifen Wu, Erick Young
  • Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
    Patent number: 6974870
    Abstract: Disclosed are compounds of formula (I): wherein R1 and R2 are defined herein, which are useful as inhibitors of the kinase activity of the I?B kinase (IKK) complex. The compounds are therefore useful in the treatment of IKK mediated diseases including autoimmune diseases inflammatory diseases and cancer. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.
    Type: Grant
    Filed: December 6, 2003
    Date of Patent: December 13, 2005
    Assignee: Boehringer Ingelheim Phamaceuticals, Inc.
    Inventors: Charles L. Cywin, Can Mao, Jonathan Emeigh, Roman Wolfgang Fleck, Ming-Hong Hao, Eugene Hickey, Weimin Liu, Daniel Richard Marshall, Tina Morwick, Peter Nemoto, Ronald John Sorcek, Sanxing Sun, Jiang-Ping Wu, Erick Young, Darren DiSalvo, John Ginn, Pier Cirillo
  • Cathepsin S inhibitors
    Publication number: 20050222145
    Abstract: This invention relates to peptidyl compounds of the formulas (I) and (II) active as cathepsin S, a cysteine protease, inhibitors. The compounds are selective, reversible inhibitors of the cathepsin S are therefore useful in the treatment of autoimmune and other diseases. The invention also relates to processes for preparing such compounds and pharmaceutical compositions comprising them.
    Type: Application
    Filed: May 31, 2005
    Publication date: October 6, 2005
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Eugene Hickey, Wiemen Liu, Sanxing Sun, Yancey Ward, Erick Young
  • Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
    Publication number: 20050182053
    Abstract: Disclosed are compounds of formula (I): wherein the variables R1, R2, R3 and Z are described herein, which are useful as inhibitors of the kinase activity of the I?B kinase (IKK) complex. The compounds are therefore useful in the treatment of IKK mediated diseases including autoimmune diseases inflammatory diseases and cancer. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.
    Type: Application
    Filed: December 2, 2004
    Publication date: August 18, 2005
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Zhidong Chen, Pier Cirillo, Darren DiSalvo, Weimin Liu, Daniel Marshall, Lifen Wu, Erick Young
  • Pyrimidine derivatives useful as inhibitors of PKC-theta
    Publication number: 20050124640
    Abstract: Disclosed are novel compounds of formula (I): wherein R1, R2 and R3 are as defined herein, which are useful as inhibitors of PKC-theta and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of PKC-theta, including immunological disorders and type II diabetes. This invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
    Type: Application
    Filed: September 3, 2004
    Publication date: June 9, 2005
    Applicants: Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Mario Cardozo, Derek Cogan, Charles Cywin, George Dahmann, Darren DiSalvo, John Ginn, Anthony Prokopowicz, Denice Spero, Erick Young
  • Compounds useful as reversible inhibitors of cysteine proteases
    Publication number: 20050032772
    Abstract: Disclosed are novel cathepsin S, K, F, L and B reversible inhibitory compounds of the formulas (I), (II), (Ia) and (Ib) further defined herein. The compounds are useful for treating autoimmune diseases. Also disclosed are processes for making such novel compounds.
    Type: Application
    Filed: September 9, 2004
    Publication date: February 10, 2005
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Michel Emmanuel, Leah Frye, Eugene Hickey, Weimin Liu, Tina Morwick, Denice Spero, Sanxing Sun, David Thomson, Yancey Ward, Erick Young
  • Compounds useful as reversible inhibitors of cysteine proteases
    Publication number: 20050032792
    Abstract: Disclosed are cathepsin S ,K, F, L and B reversible inhibitory compounds of the formulas (I), (II), (Ia) and (Ib) further defined herein. The compounds are useful for treating autoimmune diseases. Also disclosed are processes for making such novel compounds.
    Type: Application
    Filed: September 9, 2004
    Publication date: February 10, 2005
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Michel Emmanuel, Leah Frye, Eugene Hickey, Weimin Liu, Tina Morwick, Denice Spero, David Thomson, Yancey Ward, Erick Young
  • Pyrimidine derivatives useful as inhibitors of PKC-theta
    Publication number: 20040242613
    Abstract: Disclosed are novel compounds of formula (I): 1
    Type: Application
    Filed: January 27, 2004
    Publication date: December 2, 2004
    Applicants: Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Mario G. Cardozo, Derek Cogan, Charles Lawrence Cywin, Georg Dahmann, Darren DiSalvo, John David Ginn, Anthony S. Prokopowicz, Denice M. Spero, Erick Young
  • Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
    Publication number: 20040180922
    Abstract: Disclosed are compounds of formula (I): 1
    Type: Application
    Filed: December 6, 2003
    Publication date: September 16, 2004
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Charles L. Cywin, Can Mao, Jonathan Emeigh, Roman Wolfgang Fleck, Ming-Hong Hao, Eugene Hickey, Weimin Liu, Daniel Richard Marshall, Tina Morwick, Peter Nemoto, Ronald John Sorcek, Sanxing Sun, Jiang-Ping Wu, Erick Young, Darren DiSalvo, John Ginn, Pier Cirillo